Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2003
08/19/2003US6608177 Mutation of serine replaced with cysteine; use as anti-HIV, anti-allergic or anti- inflammatory agents
08/19/2003US6607906 Use in assaying compounds to determine effects on cell growth
08/19/2003US6607904 Peptidyl prolyl cis-trans isomerases
08/19/2003US6607883 Domains; amino acid fragments; 3'-5' exonuclease; nucleic acid synthesis; polymerase chain reaction (PCR); kits; use for production of chimeras and use of chimeras for production of nucleic acids during PCR
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607880 Methods and reagents for modulating apoptosis
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003US6607729 Surface antigen
08/19/2003US6607728 Compounds and methods for the diagnosis and treatment of ehrlichia infection
08/19/2003US6607726 Human tumor necrosis factor receptor TR10
08/19/2003CA2165953C Prostaglandin receptor ep3 and dna encoding it
08/19/2003CA2142819C Glucagon receptors
08/19/2003CA2122613C Targeted delivery of virus vector to mammalian cells
08/19/2003CA2012414C Hog cholera virus vaccine and diagnostic
08/14/2003WO2003067262A2 Methods and compositions involving the hsp90 activator aha1
08/14/2003WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066864A2 Method for predicting the expression efficiency in cell-free expression systems
08/14/2003WO2003066855A1 Swine rag-1 gene and utilization thereof
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066818A2 Secretion, transcription and sporulation genes in bacillus clausii
08/14/2003WO2003066809A2 Mismatch endonucleases and methods of use
08/14/2003WO2003066801A2 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system.
08/14/2003WO2003066681A1 Stabilization of protein preparations
08/14/2003WO2003066676A1 Production process of recombinant placental growth factor
08/14/2003WO2003066665A2 Proteolytic fermenter
08/14/2003WO2003066664A2 Complex technologies using enzymatic protein hydrolysate
08/14/2003WO2003066663A2 Peptides for recognition and targeting of glial cell tumors
08/14/2003WO2003066661A2 Human dr4 antibodies and uses thereof
08/14/2003WO2003066093A1 A continuous cell line for the production of vaccines
08/14/2003WO2003066092A1 A method of producing and using heat shock proteins
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003066002A2 IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003040352A9 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003020765A3 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003002713A3 Antibodies to opgl
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002085924A3 ANTI-α3(IV)NC1 MONOCLONAL ANTIBODIES AND ANIMAL MODEL FOR HUMAN ANTI-GLOMERULAR BASEMENT MEMBRANE AUTOANTIBODY DISEASE
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002055560A3 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
08/14/2003WO2002048377A3 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002016584A3 Process for the preparation of neutrophil inhibitory factor
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003US20030153733 Antibiotic resistant drug screening; vaccines
08/14/2003US20030153732 Novel polypepetide
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153066 Isolating nucleic acid putatively encoding the viral gene from the viral genome; programming a cell-free translation system with such nucleic acid, determine if capsid assembly has occurred which indicates that viral gene is required
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153048 Novel proteins and methods for producing the proteins
08/14/2003US20030153047 AIB1, a novel steroid receptor co-activator
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030153045 Methods and compositions for protein expression and purification
08/14/2003US20030153039 Using hybridomas cells; gene expression; monoclonal antibodies
08/14/2003US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153015 Compositions and methods for the treatment of immune related diseases
08/14/2003US20030153003 Growth hormone variants
08/14/2003US20030153000 Genetic engineering; culture product; recovering
08/14/2003US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152954 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
08/14/2003US20030152948 Methods for the simultaneous detection of HCV antigens and HCV antibodies
08/14/2003US20030152922 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152912 Multiple viral replicon culture systems
08/14/2003US20030152579 Controlling biosynthesis of hybrid protein; therapy against Helicobacter infections
08/14/2003US20030152571 Anti-alphabeta3 humanized monoclonal antibodies
08/14/2003US20030152560 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475326A1 A continuous cell line for the production of vaccines
08/14/2003CA2475251A1 Proteolytic fermenter
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475235A1 Production process of recombinant placental growth factor
08/14/2003CA2475071A1 Stabilization of protein preparations
08/14/2003CA2474800A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003CA2474652A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use
08/13/2003EP1335024A1 Antibody inhibiting vplf activity
08/13/2003EP1335022A1 Modification of plant cell wall component and method of regulating development differentiation
08/13/2003EP1334984A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
1 ... 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 ... 1125